• Wed, August 10, 2022

Mark Breidenbach Maintained (ALLO) at Buy with Decreased Target to $35 on, Aug 10th, 2022

Mark Breidenbach of Oppenheimer, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $40 to $35 on, Aug 10th, 2022.

Mark has made no other calls on ALLO in the last 4 months.



There are 2 other peers that have a rating on ALLO. Out of the 2 peers that are also analyzing ALLO, 1 agrees with Mark's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jack Allen of "Baird" Initiated at Hold and Held Target at $11 on, Friday, June 3rd, 2022


This is the rating of the analyst that currently disagrees with Mark


  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $32 on, Friday, July 15th, 2022

Like: 👍